Navigation Links
Ariel Pharmaceuticals, Inc. Acquires Novel Compound for Acute Migraine
Date:9/21/2011

BROOMFIELD, Colo., Sept. 21, 2011 /PRNewswire/ -- Ariel Pharmaceuticals, Inc., a private, specialty pharmaceutical company focused on the development and commercialization of products for acute central nervous system (CNS) diseases and trauma, announced today that it has in-licensed its lead product, AP-1531, for the treatment of acute migraine attacks, from the specialist healthcare company BTG International Ltd (LSE: BGC).

While the precise cause of migraines is not fully understood, changes in vascular tone and inflammatory processes appear to be key contributing factors.  Prostaglandins are naturally existing molecules that are integral components of both vascular and inflammatory reactions in the central and peripheral nervous systems.   There is evidence to demonstrate that prostaglandin E2 (PGE2) binding to the EP4 receptor causes dilation of small blood vessels in the brain, while leaving coronary and pulmonary arteries unaffected, and can stimulate a variety of inflammatory mechanisms.  AP-1531 is a potent and selective EP4 receptor antagonist that specifically targets PGE2-EP4 binding which may treat migraines. AP-1531 has shown promising results  in several disease models of migraine and acute pain and inflammation.  

"We are extremely pleased with the data from six Phase I studies on AP-1531 and are confident this approach will yield positive results as we initiate a Phase 2 study in migraine patients in 2012," said Steve Orndorff, President and CEO of Ariel Pharmaceuticals.  "Given that the current standard of care for moderate to severe migraines can take up to 90 minutes to provide relief and works temporarily or not at all in many patients, in addition to having potentially serious side effects, we're committed to developing a safer and more efficacious alternative that will provide better quality care to patients.  We believe AP-1531 will validate our business model of in-licensing clinic-ready dru
'/>"/>

SOURCE Ariel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Ariel Ways GovBuys Awarded VA Contract
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
7. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
8. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
9. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
10. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
11. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... YORK , May 22, 2013 While ... their teens, friends to drink at home under adult ... about drinking, the truth is that there are serious ... Partnership at Drugfree.org and The Treatment Research ... new, interactive web resource for parents and caregivers to ...
(Date:5/22/2013)... 2013 PRNewswire – iBio, Inc. (NYSE ... vaccine candidate for the newly emerged H7N9 influenza ... the iBioLaunch™ platform. This validation milestone was achieved ... sequence information to purification of recombinant protein. ... The iBioLaunch platform eliminates the need to ...
(Date:5/22/2013)... 22, 2013 WomanCare Global recently launched ... an extensive training initiative attended by 90 health ... ) (Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) Simplant, ... highly effective subdermal implant composed of two thin, ... (a synthetic form of the hormone progestin). These ...
Breaking Medicine Technology:Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 2Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 3Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 4Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 5Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 6Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 7iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2
... SAN DIEGO, Feb. 3, 2011 Neurocrine Biosciences, Inc. (Nasdaq: ... report its fourth quarter and year-end 2010 financial results after ... will then host a live conference call and webcast to ... afternoon, February 10, 2011 at 5:00 p.m. Eastern Time (2:00 ...
... 2011 SkinMedica, Inc., the fastest-growing professional skin ... that it is introducing a new, fast-acting anti-redness ... in over two decades.  It is the first ... visible redness.     (Photo: ...
Cached Medicine Technology:SkinMedica Launches Redness Relief CalmPlex™ 2SkinMedica Launches Redness Relief CalmPlex™ 3
(Date:5/22/2013)... 22, 2013 According to the National ... disorder effecting up to 3 million people in the ... the small intestine and mal-absorption of nutrients(2). To protect ... constipation, weight loss and vitamin deficiency, people with celiac ... are many gluten-free foods that celiac sufferers can eat, ...
(Date:5/22/2013)... 2013: New research shows that craving drugs such ... of the brain that are implicated in determining ... in motivation. Dr. Alain Dagher, from McGill ... regions could underlie addiction. These results were presented ... meeting of the Canadian Association for Neuroscience - ...
(Date:5/22/2013)... May 22 (HealthDay News) -- Roughly four in 10 ... pulmonary disease (COPD) actually do not have the lung ... Faulty diagnoses were made based on an evaluation of ... standard" disease test known as spirometry, which shows how ... amount of air they can exhale and how long ...
(Date:5/22/2013)... University of Melbourne said this small increase in cancer ... CT scans in diagnosing and monitoring disease. , The ... Journal today and involved researchers at eight other ... for Research on Cancer in Lyon, France. , ... providing detailed three dimensional pictures to diagnose or exclude ...
(Date:5/22/2013)... King of Prussia, PA (PRWEB) May 22, 2013 ... is proud to announce its participation in the Greater Philadelphia ... experienced cyclists and recreational riders who are passionate about stopping ... affects more than 25 million Americans. , The Tour ... Ambler Campus, located at 580 Meetinghouse Road in Ambler, 30 ...
Breaking Medicine News(10 mins):Health News:During Celiac Awareness Month, Nutrition Expert Keri Glassman Encourages People with Celiac Disease to Find a Fiber Alternative like Konsyl Original Formula 2Health News:During Celiac Awareness Month, Nutrition Expert Keri Glassman Encourages People with Celiac Disease to Find a Fiber Alternative like Konsyl Original Formula 3Health News:Addiction as a disorder of decision-making 2Health News:COPD May Be Over-Diagnosed Among Uninsured 2Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3
... Md., May 5 /PRNewswire-Asia/ -- Chindex International, Inc.,("Chindex" ... a leading independent American,provider of Western healthcare products ... announced that the Company is scheduled to participate ... held May 19-21, 2009, at,300 Madison Avenue in ...
... to Hydroxycut?DEERFIELD BEACH, Fla., May 5 The ... body blow on Friday when the FDA declared ... unsafe for human consumption and warned users to ... were taking Hydroxycut.With increasing awareness that being even ...
... New Survey From National Ovarian Cancer Coalition Says Gynecologic ... To Economic FactorsDALLAS, May 5 At Mother,s Day, ... (NOCC), www.ovarian.org , reveals some startling ... women expect the economy will impact their gynecological health ...
... The Better Hearing Institute (BHI) launched today a public ... Up in a Down Economy. The campaign focuses on ... opportunities. BHI is encouraging people of all ages who ... their jobs to make sure that unaddressed hearing loss ...
... nearly Free Tuesdays, Stonebrook Manor in Thornton, CO is offering a limited ... wedding reception hall. Rules and Restrictions apply, visit www.stonebrookmanor.com ... ... or not, the dreams of a little girl of her wedding day ...
... of growth plate injuries is key to putting an adolescent athlete back ... issue of Sports Health: A Multidisciplinary Approach. , ... Rosemont, IL (Vocus) ... is key to putting an adolescent athlete back in the game, according ...
Cached Medicine News:Health News:Chindex International, Inc. Announces May Conference Participation 2Health News:Dieters Dealt a Body Blow From Recent Labeling of Hydroxycut as Unsafe for Human Consumption 2Health News:Women's Gynecological Exams: Another Victim of the Troubled Economy? 2Health News:Listening Up in a Down Economy: Better Hearing Institute Launches Public Service Campaign for Better Hearing and Speech Month 2Health News:Listening Up in a Down Economy: Better Hearing Institute Launches Public Service Campaign for Better Hearing and Speech Month 3Health News:Stonebrook Manor Gives Away Luxurious Wedding Receptions in Colorado 2Health News:Stonebrook Manor Gives Away Luxurious Wedding Receptions in Colorado 3Health News:Adolescent Growth Plate Injuries May Be Related to Overuse 2
... BODI™ Dynamic Orthosis is the dynamic way ... over time is proven effective in reducing ... the time of other therapies. Can also ... For all joint stiffness and soft tissue ...
... The Infrapatellar Band uses ... on the patellar tendon helping ... Schlatter and patella tendonitis. Focusing ... the tibial tubercle with less ...
... Provides shoulder ... range of motion ... rotator cuff tears, ... The shoulder brace ...
Shoulder Subluxation Inhibitor (SSI) is an ideal bracing system to keep athletes on the field by reducing the risk of shoulder injury. The SSI is the only brace that allows TOTAL ANTERIOR RANGE OR MO...
Medicine Products: